Clinical Trial Update: Cost Analysis for Endoscopic Retrograde Cholangiopancreatography (ERCP) [NA]

View source ↗

Summary

A clinical trial evaluating the cost analysis of endoscopic retrograde cholangiopancreatography (ERCP) for biliary obstruction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Obstruction

Snippet

Sponsor: University of Oklahoma | Conditions: Biliary Obstruction | NA | Status: WITHDRAWN